首页> 外文期刊>Chemical and Pharmaceutical Bulletin >Application of Alginate Gel as a Vehicle for Liposomes. I. Factors Affecting the Loading of Drug-Containing Liposomes and Drug Release
【24h】

Application of Alginate Gel as a Vehicle for Liposomes. I. Factors Affecting the Loading of Drug-Containing Liposomes and Drug Release

机译:海藻酸盐凝胶作为脂质体载体的应用。一,影响含药脂质体负荷和药物释放的因素

获取原文
获取原文并翻译 | 示例
           

摘要

To explore the feasibility of alginate gel as a vehicle for liposomes, we investigated the effects of various factors associated with the loading of drug-containing liposomes into the gel beads. The loading process includes (1) mixing of liposomes and alginate solution, (2) calcium induced gelation of alginates, (3) the time-dependent contraction of a gel body squeezing out interior water, and (4) possible leakage or release of a drug entrapped in liposomes in a series of each of theses processes. These effects were examined in terms of the leakage of a marker 5(6)-carboxyfluorescein (CF) from liposomes of egg phosphatidylcholine (EPC) and EPC/cholesterol (EPC/Cho) and Iiposomc (phosphorus) release from curing and fully-cured gel beads whose initial polymer concentrations were 4 and 2%. Major findings were: (1) Alginate induced the leakage of a water-soluble drug incorporated in the liposomes as a function of the polymer concentration and the mixing time. (2) Calcium ions also stimulated the leakage of the drug. EPC/Cho liposomes were several times more resistant to the leakage of CF than were EPC liposomes. (3) The liposomes were well loaded without any loss in the gel bead despite the squeezing outflow of water and the bead contraction during gel curing. (4) Such curing caused leakage of the drug from the EPC liposomes in the very early stage while no effect was observed in the EPC/Cho liposomes. (5) In the gel-eroding medium (pH 7.4 Tris-HCl, 37°C), the total drug release was controlled by the erosion rate of the bead body. Immediately after the bead erosion, EPC liposomes retained about 60% of the drug in the 2% bead and only about 20% in the 4% bead, whereas EPC/Cho liposomes retained more than 85% regardless of the initial alginate concentration. The results provide valuable information for the design and applicability of the gel-loaded Iiposomc delivery system.
机译:为了探索藻酸盐凝胶作为脂质体载体的可行性,我们研究了与将含药物脂质体负载到凝胶珠粒中相关的各种因素的影响。加载过程包括(1)脂质体和藻酸盐溶液的混合;(2)钙诱导的藻酸盐凝胶化;(3)凝胶体随时间的收缩挤压出内部水;以及(4)可能泄漏或释放这些过程中的每个过程都将药物包裹在脂质体中。根据标记5(6)-羧基荧光素(CF)从鸡蛋磷脂酰胆碱(EPC)和EPC /胆固醇(EPC / Cho)和Iiposomc(磷)的脂质体中泄漏出来的情况进行了检查初始聚合物浓度为4%和2%的凝胶珠。主要发现是:(1)藻酸盐诱导掺入脂质体中的水溶性药物的泄漏,这是聚合物浓度和混合时间的函数。 (2)钙离子也刺激了药物的泄漏。 EPC / Cho脂质体对CF泄漏的抵抗力是EPC脂质体的几倍。 (3)尽管在凝胶固化过程中水的挤出和珠子的收缩,脂质体负载良好,而在珠子中没有任何损失。 (4)这种固化在非常早期就引起药物从EPC脂质体中泄漏,而在EPC / Cho脂质体中未观察到作用。 (5)在凝胶腐蚀介质(pH 7.4 Tris-HCl,37°C)中,总药物释放受珠体的腐蚀速率控制。珠腐蚀后,EPC脂质体在2%的珠中立即保留约60%的药物,而在4%的珠中仅保留约20%的药物,而无论初始藻酸盐浓度如何,EPC / Cho脂质体均保留超过85%的药物。结果为凝胶负载的脂质体递送系统的设计和适用性提供了有价值的信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号